The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core
- PMID: 11026535
- DOI: 10.1016/s0968-0896(00)00155-3
The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core
Abstract
The three-dimensional structure of the complex between an HIV-1 cell-entry inhibitor selected from screening a combinatorial library of non-natural building blocks and the central, trimeric, coiled-coil core of HIV-1 gp41 has been determined by X-ray crystallography. The biased combinatorial library was designed to identify ligands binding in nonpolar pockets on the surface of the coiled-coil core of gp41. The crystal structure shows that the non-peptide moiety of the inhibitor binds to the targeted cavity in two different binding modes. This result suggests a strategy for increasing inhibitor potency by use of a second-generation combinatorial library designed to give simultaneous occupancy of both binding sites.
Similar articles
-
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.Nat Struct Biol. 1999 Oct;6(10):953-60. doi: 10.1038/13324. Nat Struct Biol. 1999. PMID: 10504731
-
Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.Biochemistry. 2000 Feb 22;39(7):1634-42. doi: 10.1021/bi9921687. Biochemistry. 2000. PMID: 10677212
-
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.Biochem Biophys Res Commun. 2000 Mar 24;269(3):641-6. doi: 10.1006/bbrc.1999.1972. Biochem Biophys Res Commun. 2000. PMID: 10720469 Review.
-
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7. doi: 10.1073/pnas.95.26.15613. Proc Natl Acad Sci U S A. 1998. PMID: 9861018 Free PMC article.
-
Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.Eur J Med Chem. 2011 Apr;46(4):979-92. doi: 10.1016/j.ejmech.2011.01.046. Epub 2011 Feb 3. Eur J Med Chem. 2011. PMID: 21345545 Review.
Cited by
-
HIV-1 envelope accessible surface and polarity: clade, blood, and brain.Bioinformation. 2011 Mar 22;6(2):48-56. doi: 10.6026/97320630006048. Bioinformation. 2011. PMID: 21544164 Free PMC article.
-
Changing selective pressure during antigenic changes in human influenza H3.PLoS Pathog. 2008 May 2;4(5):e1000058. doi: 10.1371/journal.ppat.1000058. PLoS Pathog. 2008. PMID: 18451985 Free PMC article.
-
Computer-Aided Approaches for Targeting HIVgp41.Biology (Basel). 2012 Aug 20;1(2):311-38. doi: 10.3390/biology1020311. Biology (Basel). 2012. PMID: 23730525 Free PMC article.
-
Binding of small-molecule ligands to proteins: "what you see" is not always "what you get".Structure. 2009 Apr 15;17(4):489-98. doi: 10.1016/j.str.2009.02.010. Structure. 2009. PMID: 19368882 Free PMC article. Review.
-
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127. Viruses. 2013. PMID: 23344560 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases